Search Results for "free ce"

The second edition of Oncology Nurse Navigation: Delivering Patient-Centered Care Across the Continuum provides novice and experienced nurse navigators with an overview of the role of the nurse navigator in cancer care.

The first innovation in stem cell mobilization for multiple myeloma in a decade, motixafortide (Aphexda™) received U.S. Food and Drug Administration approval on September 11, 2023. The drug’s clinical trial demonstrated that one dose of motixafortide plus filgrastim enabled a majority of patients to achieve the collection goal of at least six million hematopoietic stem cells.

Propensity to adhere to cervical cancer screening recommendations varies widely by sexual orientation, researchers reported in study findings published in Cancer. They found that those in sexual minority groups are nearly 50% less likely to have ever undergone a Pap test.